RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers

Clinical trial NCT04037358 · COMPLETED

Trial details

NCT number: NCT04037358
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2019-08-09
Primary completion: 2025-07-15
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.